Qiang Liu, MD, PhD, is an assistant professor in the Department of Neurobiology at Barrow Neurological Institute and adjunct assistant professor in the Department of Neurology at University of Arizona College of Medicine – Phoenix.
Dr. Liu is a member of the American Academy of Neurology, American Heart Association/American Stroke Association, AAA Science, and the Society for Neuroscience.
Dr. Liu received his medical degree from Nanjing Medical University, Nanjing, China and received his doctorate in neuroscience from Arizona State University. He completed his fellowship at Barrow Neurological Institute in immunology.
Dr. Liu’s research interests include basic and translational studies on innate immunity and inflammation in central nervous system tissue injury and repair, neuronal regulation of immune responses, and damage associated molecular pattern (DAMP) molecules-triggered neurodegeneration.
- Postdoctoral Fellowship, Barrow Neurological Institute, Immunology, 2012
- PhD, Arizona State University, Neuroscience, 2011
- MS, Nanjing Medical University, Neuropharmacology, Nanjing, China, 2006
- MD, Nanjing Medical University, 2003
- Society for Neuroscience
- AAA Science
- Alzheimer’s Research Forum
- American Academy of Neurology
- American Heart Association
- American Heart Association
- American Association of Immunologists
- Scientist Development Award, American Heart Association, 2015
- Graduate Research Award, Arizona State University, 2011
- Liu Q, Jin WN, Liu Y, Shi K, Sun H, Zhang F, Zhang C, Gonzales RJ, Sheth KN, La Cava A, Shi FD. Brain ischemia suppresses immunity in the periphery and brain via different neurogenic innervations. Immunity. 2017;46(3):474-487.
- Li M, Ren H, Sheth KN, Shi FD, Liu Q. A TSPO ligand attenuates brain injury after intracerebral hemorrhage. FASEB J. 2017;31(8):3278-3287.
- Li M, Li Z, Yao Y, Jin WN, Wood K, Liu Q, Shi FD, Hao J. Astrocyte-derived interleukin-15 exacerbates ischemic brain injury via propagation of cellular immunity. Proc Natl Acad Sci U S A. 2017;114(3):E396-E405.
- Jin WN, Shi SX, Li Z, Li M, Wood K, Gonzales RJ, Liu Q. Depletion of microglia exacerbates postischemic inflammation and brain injury. J Cereb Blood Flow Metab. 2017;37(6):2224-2236.
- Liu Q, Sanai N, Jin WN, La Cava A, Van Kaer L, Shi FD. Neural stem cells sustain natural killer cells that dictate recovery from brain inflammation. Nat Neurosci. 2016;19(2):243-252.
- Jin WN, Yang X, Li Z, Li M, Shi SX, Wood K, Liu Q, Fu Y, Han W, Xu Y, Shi FD, Liu Q. Non-invasive tracking of CD4+ T cells with a paramagnetic and fluorescent nanoparticle in brain ischemia. J Cereb Blood Flow Metab. 2016;36(8):1464-1476.
- Zhu Z, Fu Y, Tian D, Sun N, Han W, Chang G, Dong Y, Xu X, Liu Q, Huang D, Shi FD. Combination of the Immune Modulator Fingolimod With Alteplase in Acute Ischemic Stroke: A Pilot Trial. Circulation. 2015;132(12):1104-1112.
- Gan Y, Liu Q, Wu W, Yin JX, Bai XF, Shen R, Wang Y, Chen J, La Cava A, Poursine-Laurent J, Yokoyama W, Shi FD. Ischemic neurons recruit natural killer cells that accelerate brain infarction. Proc Natl Acad Sci U S A. 2014;111(7):2704-2709.
- Liu Q, Xie X, Lukas RJ, St John PA, Wu J. A novel nicotinic mechanism underlies beta-amyloid-induced neuronal hyperexcitation. J Neurosci. 2013;33(17):7253-7263.
- Liu Q, Huang Y, Xue F, Simard A, DeChon J, Li G, Zhang J, Lucero L, Wang M, Sierks M, Hu G, Chang Y, Lukas RJ, Wu J. A novel nicotinic acetylcholine receptor subtype in basal forebrain cholinergic neurons with high sensitivity to amyloid peptides. J Neurosci. 2009;29(4):918-929.